nano tech in Tokyo: IVAM joint pavilion presented the enormous range of nanotechnology

The exhibitors of the IVAM joint pavilion in 2017 IVAM

At the joint pavilion of the IVAM Microtechnology Network, which was organized under the headline “Nano in Germany”, 14 companies showcased their innovations.

The exhibitors on-site presented cost-effective manufacturing processes of specific nanoparticles, 3D production of printed nanoscales, commercial production of graphene, an important new nano material for a wide range of applications, or manufacturing of nanomaterials for applications in the fields of energy and environment.

In addition, nanotech solutions in the field of surface processing for the automotive industry, nanostructured membranes, e.g. for fuel cell technology, and functionalized nano surfaces for medical devices have been presented.

“The various applications that were presented at the IVAM area show the enormous range of nanotechnology applications,” says Dr. Thomas R. Dietrich, Managing Director of IVAM. “The exhibitors on-site were very satisfied with the response from the visitors.”

The IVAM exhibitors were able to make and maintain contacts with Japanese companies even outside the exhibition. The supporting program included, for example, a ceremonial opening with a traditional sake ceremony.

IVAM Managing Director Dr. Thomas Dietrich was allowed to open the sake barrel ceremoniously with a wooden hammer as deputy for Germany together with other guests of honor. Furthermore, the companies of the IVAM pavilion attended a reception of the German Embassy with the Minister of Economic Affairs of Saxony.

Because of the positive outcome of the fair IVAM reserved space for another German pavilion at nano tech 2018. Detailed information will be available soon from IVAM Microtechnology Network.

https://www.ivam.de/news/PM_Nanotech17_2?lang=en

Media Contact

Mona Okroy-Hellweg idw - Informationsdienst Wissenschaft

All latest news from the category: Trade Fair News

Back to home

Comments (0)

Write a comment

Newest articles

After 25 years, researchers uncover genetic cause of rare neurological disease

Some families call it a trial of faith. Others just call it a curse. The progressive neurological disease known as spinocerebellar ataxia 4 (SCA4) is a rare condition, but its…

Lower dose of mpox vaccine is safe

… and generates six-week antibody response equivalent to standard regimen. Study highlights need for defined markers of mpox immunity to inform public health use. A dose-sparing intradermal mpox vaccination regimen…

Efficient, sustainable and cost-effective hybrid energy storage system for modern power grids

EU project HyFlow: Over three years of research, the consortium of the EU project HyFlow has successfully developed a highly efficient, sustainable, and cost-effective hybrid energy storage system (HESS) that…

Partners & Sponsors